Back to LGND Stock Lookup

Ligand Pharma (LGND) –

Apr 24, 2015 04:10 PM Form 8-K LIGAND PHARMACEUTICALS For: Apr 24
Apr 24, 2015 08:00 AM Ligand to Participate in Two Upcoming Investor Conferences
Apr 23, 2015 05:07 PM Ligand Pharma (LGND) Names Interim Chief Financial Officer
Apr 23, 2015 04:08 PM Form 8-K LIGAND PHARMACEUTICALS For: Apr 23
Apr 23, 2015 04:06 PM Ligand to Report First Quarter Results on May 11th
Apr 23, 2015 04:01 PM Ligand Names Melanie J. Herman Interim Chief Financial Officer
Apr 22, 2015 12:00 PM Ligand Earns Milestone from SAGE Therapeutics for SAGE-547
Apr 20, 2015 07:41 AM Ligand Pharma (LGND) Announces Presentation of IRAK4 Inhibitor Compounds Data at AACR 2015
Apr 20, 2015 07:40 AM Ligand Partner TG Therapeutics Presents Positive Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research (AACR) Annual Meeting
Apr 14, 2015 08:30 AM Ritter Pharmaceuticals Names Paul V. Maier to its Board of Directors
Apr 10, 2015 08:59 AM Ligand Pharma (LGND), Viking Therapeutics Enter Amended MLA: Calls for Increased Royalty Rates
Apr 10, 2015 08:55 AM Form 8-K LIGAND PHARMACEUTICALS For: Apr 08
Mar 30, 2015 10:41 AM Roth Affirms Ligand (LGND) at 'Buy' Following Amgen (AMGN), Spectrum (SPPI) Updates
Mar 30, 2015 07:12 AM Spectrum Pharma (SPPI) Issues Encouraging Update on Captisol-Enabled Melphalan vs. Current Market Leader
Mar 30, 2015 07:00 AM Spectrum Pharmaceuticals Presents New Data on EVOMELATM (CE-Melphalan), at the Annual Meeting of the American Pharmacists Association (APhA) in San Diego, Highlighting Stability
Mar 20, 2015 04:45 PM Form 4 LIGAND PHARMACEUTICALS For: Mar 19 Filed by: Patel Sunil
Mar 18, 2015 04:33 PM Form 4 LIGAND PHARMACEUTICALS For: Mar 16 Filed by: Berkman Charles S
Mar 9, 2015 07:05 AM Spectrum Pharma (SPPI) Announces FDA Acceptance of CE-Melphalan NDA
Mar 9, 2015 07:00 AM Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan
Mar 3, 2015 04:06 PM Form 4 LIGAND PHARMACEUTICALS For: Mar 02 Filed by: Herman Melanie J
Mar 3, 2015 08:30 AM Ligand to Present at the 27th Annual Roth Conference on March 9th
Mar 2, 2015 02:24 PM Roth Capital Positive on Ligand Pharma (LGND); Kyprolis Met Primary Endpoint in ENDEAVOR Trial (AMGN)
Feb 23, 2015 04:34 PM Form 10-K LIGAND PHARMACEUTICALS For: Dec 31
Feb 20, 2015 04:50 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 19 Filed by: Herman Melanie J
Feb 17, 2015 04:41 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BIOTECHNOLOGY VALUE FUND L P
Feb 13, 2015 10:21 AM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: FMR LLC
Feb 12, 2015 05:07 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: RS INVESTMENT MANAGEMENT CO LLC
Feb 12, 2015 01:43 PM Form SC 13G LIGAND PHARMACEUTICALS Filed by: CARDINAL CAPITAL MANAGEMENT LLC /CT
Feb 12, 2015 07:00 AM Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting
Feb 11, 2015 08:07 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: Herman Melanie J
Feb 11, 2015 08:07 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: FOEHR MATTHEW W
Feb 11, 2015 08:06 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: DeSilva Nishan M
Feb 11, 2015 08:06 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: Berkman Charles S
Feb 11, 2015 08:05 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: HIGGINS JOHN L
Feb 10, 2015 02:47 PM Form SC 13G LIGAND PHARMACEUTICALS Filed by: VANGUARD GROUP INC
Feb 9, 2015 08:50 AM Form 8-K LIGAND PHARMACEUTICALS For: Feb 09
Feb 9, 2015 08:31 AM Ligand Pharma (LGND) Reports In-Line Q4 EPS; Issues Light Q1 Outlook
Feb 9, 2015 08:30 AM Ligand Reports Fourth Quarter and Full Year 2014 Financial Results
Feb 9, 2015 07:00 AM Ritter Pharmaceuticals Names Matthew W. Foehr to Its Board of Directors
Feb 6, 2015 02:16 PM Trading Radar for 2/9: Hasbro (HAS), Loews (L), Wex, Inc. (WEX), Computer Sciences (CSC) Report
Feb 6, 2015 09:15 AM Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission Seeking Additional Indication for Revolade®
Feb 4, 2015 04:16 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BLAIR WILLIAM & CO/IL
Feb 3, 2015 10:18 AM Ligand's (LGND) License with Sermonix Demonstrates Great Example of Core Business Model - Roth Capital
Feb 3, 2015 10:12 AM Ligand Pharma (LGND), Sermonix Enter Licensing Agreement for Lasofoxifene
Feb 3, 2015 08:30 AM Ligand Signs License Agreement with Sermonix for Lasofoxifene
Feb 2, 2015 04:49 PM Form 8-K LIGAND PHARMACEUTICALS For: Jan 27
Feb 2, 2015 04:30 PM Ligand Promotes Matthew W. Foehr to President
Jan 28, 2015 08:30 AM Ligand to Present at BIO CEO and RBC Capital Markets Global Healthcare Conferences in February
Jan 28, 2015 07:57 AM Roth Remains Positive on Ligand (LGND) Following Kyprolis Q4 Sales Data, sNDA Filing (AMGN)
Jan 27, 2015 09:00 AM Ligand to Report Fourth Quarter Results on February 9th

Back to LGND Stock Lookup